Company: HRTX
Filing Date: 2025-04-30
Form Type: DEFA14A
Source: 0000950170-25-060884
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEFA14A
Chunk 1
---
@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visitwww.ProxyVote.comControl 

# Smartphone users Point your camera here and vote without entering a control number Vote Virtually at the Meeting* June 12, 2025 9:00 AM Eastern Time Virtually at:www.virtualshareholdermeeting.com/HRTX2025*Please check the meeting materials for any special requirements for meeting attendance.
Vote atwww.ProxyVote.comTHIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Voting Items Board Recommends V74543-P28909 1. To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Nominees: 1a. Craig Collard For 1b. Sharmila Dissanaike, M.D., FACS, FCCM For 1c. Craig Johnson For 1d. Michael Kaseta For 1e. Adam Morgan For 1f. Christian Waage For 2. To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2025. For 3. To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2024. For 4. To approve, on a nonbinding advisory basis, the frequency of future advisory votes on the compensation paid to our Named Executive Officers. 1 Year 5. To transact such other business as may properly come before the Annual Meeting. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V74543-P28909